Research & Development: Page
-
PharmaVoice Team/PharmaVoice
Cover
PharmaVOICE 100 of the Most Inspiring People July/August 2007 Download PDF
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Adaption Adoption
By Denise Myshko The double-blind, randomized, parallel group design of clinical trials is so entrenched with well-established processes and systems in the industry that to even consider a change in structure may seem like an uphill battle. But many in the pharmaceutical industry — from pharmaceu...
By Denise Myshko • Jan. 2, 2008 -
Explore the Trendline➔
Getty Images
TrendlineArtificial intelligence & machine learning
After years of excited buzz around the potential of artificial intelligence and machine learning, pharma has begun to realize the true implications and potential value of these technologies.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
UpFront
An international connection Internet and Physicians in Latin America As in the rest of the world, healthcare professionals from across Latin America use the Internet to be informed, and surprisingly, a majority use their free time to do so. A recent survey by Medimix International shows that most...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Managed Markets: Workers' Comp Pharmacy Costs Rising
By Denise Myshko Total spend for drugs in the workers’ compensation arena is expected to be $5.5 billion in 2007 and represents 15% of total medical costs associated with workers’ compensation. This is the fastest growing component of the system’s medical expense. The use of generic drugs is sign...
By Denise Myshko • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
On behalf of the PharmaLinx LLC family, I would like to thank all of those who contributed to the success of the 7th annual charity golf event. Seven years ago, believe it or not, we — Lisa Banket, Marah Walsh, and myself — not only founded the company and began publishing PharmaVOICE but establi...
By Taren Grom • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Sales, Marketing, and R&D Trends from Industry Lipitor Perceived as Market Leader Among Statin Brands When it comes to statins, the most frequently discussed issue in the blogosphere and general online world is the negative side effects. This is one of the findings in a recent report fielded ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
UpFront
Online update SURF’s UP According to Manhattan Research’s latest study, physician site traffic is spread among product sites of new and early-launch stage treatments, those with clinical news coverage, and, consistent with years past, products with a significant consumer advertising component. “W...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Table of Contents
Table of Contents September 2007 On the Cover Success Beyond the Silos Innovative pharmaceutical companies are redefining the communications process by tearing down the walls between the different factions: agencies, sales, marketing, and public relations. FEATURES Postmarketing Safety in the Spo...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Postmarketing Safety in the Spotlight
Improving prescription drug safety and oversight have taken center stage both within Congress and with regulatory authorities. Postmarketing research is an important element of commercialization that enables companies to expand existing markets, enter new markets, develop and deliver messaging th...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Success Beyond the Silos
By Robin Robinson Forum Innovative pharmaceutical companies are redefining the communications process by tearing down the walls between the different factions: agencies, sales, marketing, and public relations. More and more pharmaceutical companies are breaking out of their siloed structure to re...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Marketplace
Featured Product and Service Showcases AmerisourceBergen Specialty Group Axis Healthcare Communications LLC Cadent Medical Communications The Center for Biomedical Continuing Education CME LLC cme2 The Curry Rockefeller Group LLC Excerpta Medica Innovia Education Institute LLC Institu...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
The State of CME
August 2007 VIEW on Medical Education The State of CME by Kate Guerriero Continuing medical education could be argued to be one of the most ever-changing fundamentals in the healthcare industry today. Ensuring that CME remains in compliance ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Managed Markets: Pharmacists
Playing a Pivotal Role Experts believe that pharmacists are ideally positioned to help patients better manage their drug therapies, as such they play a pivotal role helping seniors navigate the new Medicare Part D prescription drug plan. By Denise Myshko Pharmacists across the United States conti...
By Denise Myshko • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
The Commanders & Chiefs
These champions of industry demonstrate their commitment to their employees, their companies, and their communities by setting high personal and corporate standards. Mehmood Khan, M.D. Mehmood Khan, M.D.’s favorite quote is from Michelangelo: Ancora Imparo, which translates into “I am still learn...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
With so much negative press these days surrounding the pharmaceutical and life-sciences industries, it is our pleasure to once again be able to relate the positive aspects of our industry. We want to thank the thousands of individuals who took the time to send in their thoughtful write ups as par...
By Taren Grom • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
The Patient Advocates
With an unwavering commitment to patients and protecting their rights, these forward-thinking individuals are advocating best practices for clinical-trial recruitment and education. Zane Wilson Speaking up for Those in Need Despite an often uphill battle to provide better facilities for patients ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
The Researchers & Scientists
Matthew Coffey, Ph.D. Barry Eisenstein, M.D. Robert Lanza, M.D. Christine Smith Ana Szarfman, M.D., Ph.D. From discovery through clinical development, the researchers and scientists behind the medicines are making a significant impact on the pipelines of today and of the future. Current positions...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
The Technologists
These innovators of technology-based solutions are improving connections across silos to facilitate the drug-development process and customer interactions. PharmaVOICE 100 July/August 2007 Vikas Vats The Sky’s the limit for innovation Current position VP, marketRx Place and date of Birth New Delh...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Inverting the Enrollment Trend of Clinical Trials
Inverting the Enrollment Trend of Clinical Trials One of the largest challenges facing the industry today is inverting the trend of clinical trials failing to complete enrollment on time. Raising awareness of a particular clinical trial with call-to-action advertising, such as broadcast televi...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Guidance and Technology: A Single-Source Solution
Guidance and Technology: A Single-Source Solution Rick Piazza, VP, Product Strategy In today’s technology-reliant clinical-trial studies, it is crucial that software providers maintain a staff of in-house experts to offer counsel and guidance to sponsors. These experts act as process partne...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
New Techniques Drive Patient Enrollment for Trials
New Techniques Drive Patient Enrollment for Trials The number of clinical trials for new drugs continues to grow, increasing the competition for patients. IMS data show that new drug-discovery technologies are fueling record worldwide growth. There are more than 13,000 studies projected for 20...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Clinical Services: Managing the Moving Parts
Clinical Services: Managing the Moving Parts By Taren Grom, Editor The Cost of Doing Business The cost of drug development remains on the rise, with most estimates showing that the clinical-trials stage alone accounts for 40% of all costs related to R&D. Our Forum experts discuss...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Table of Contents
Letter from the Editor The Forum Clinical Services: Managing the Moving Parts — The clinical-research process is complex and requires integrated, sophisticated processes, technologies, and management to reduce costs, improve timelines, and produce safe therapeutics. Company Listing by Topic of In...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Integration and Workflow Issues for Clinical-Services Providers to Ensure Smooth Trials
Integration and Workflow Issues for Clinical-Services Providers to Ensure Smooth Trials Mary T. Stefanzick, Associate Director of Operations An ongoing imperative in clinical research for pharma and biotech companies is to accelerate processes and timelines to get new products to market ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Overcoming Poor Quality Data for ECG Collection
Overcoming Poor Quality Data for ECG Collection Timothy Callahan, Ph.D., Chief Scientific Officer The ICH E14 has become the touchstone guideline when designing and implementing Thorough QT (TQT) trials. Even protocols that are not designed primarily as a QT trial often use recommendations fr...
By PharmaVoice Team • Jan. 2, 2008
Previous
